Oncology Research

Papers
(The median citation count of Oncology Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Galectins dysregulation: A way for cancer cells to invade and pervade47
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities35
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP134
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer29
Survival and comorbidities in lung cancer patients: Evidence from administrative claims data in Germany28
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations27
Long noncoding RNA TFAP2A AS1 exerts promotive effects in non small cell lung cancer progression via controlling the microRNA 548a 3p/CDK4 axis26
Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma26
System analysis based on the T cell exhaustion‑related genes identifies CD38 as a novel therapy target for ovarian cancer25
A novel isoxazole compound CM2-II-173 inhibits the invasive phenotype of triple-negative breast cancer cells24
The role of AFAP1-AS1 in mitotic catastrophe and metastasis of triple-negative breast cancer cells by activating the PLK1 signaling pathway21
Long non-coding RNA H19 promotes proliferation in hepatocellular carcinoma cells via H19/miR-107/CDK6 axis19
Histone deacetylase inhibitors as a novel therapeutic approach for pheochromocytomas and paragangliomas18
Prognostic-related genes for pancreatic cancer typing and immunotherapy response prediction based on single-cell sequencing data and bulk sequencing data18
Identification of lncRNAs associated with the progression of acute lymphoblastic leukemia using a competing endogenous RNAs network17
Is autophagy induction by PARP inhibitors a target for therapeutic benefit?16
The role of LIN28B in tumor progression and metastasis in solid tumor entities14
Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer14
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma13
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance13
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study13
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells12
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells12
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells11
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials11
Deoxynortryptoquivaline: A unique antiprostate cancer agent11
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer10
Integrative multiomics analysis identifies a metastasis-related gene signature and the potential oncogenic role of EZR in breast cancer10
A pan-cancer analysis identifies SOAT1 as an immunological and prognostic biomarker10
Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways10
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma9
The synergistic effects of PRDX5 and Nrf2 on lung cancer progression and drug resistance under oxidative stress in the zebrafish models9
Thioredoxin domain-containing protein 9 protects cells against UV-B-provoked apoptosis via NF-κB/p65 activation in cutaneous squamous cell carcinoma9
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma9
COVID-19 vaccine related hypermetabolic lymph nodes on PET/CT: Implications of inflammatory findings in cancer imaging9
Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study9
Progress in research on tumor microenvironment-based spatial omics technologies9
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma8
Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma8
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study8
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment8
Retraction notice to Long Noncoding RNA LINC01133 Functions as an miR-422a Sponge to Aggravate the Tumorigenesis of Human Osteosarcoma [Oncology Research 26(3) (2018) 335343]8
The zinc figure protein ZNF575 impairs colorectal cancer growth via promoting p53 transcription8
Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer8
The SMAD2/miR-4256/HDAC5/p16INK4a signaling axis contributes to gastric cancer progression8
Tumor neoantigens: Novel strategies for application of cancer immunotherapy7
Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway7
Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients7
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer7
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape7
circRNAs in drug resistance of breast cancer7
CircMAN1A2 promotes vasculogenic mimicry of nasopharyngeal carcinoma cells through upregulating ERBB2 via sponging miR-9407
Identification of microbial metabolites that accelerate the ubiquitin-dependent degradation of c-Myc7
LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway7
Deciphering key genes involved in cisplatin resistance in kidney renal clear cell carcinoma through a combined in silico and in vitro approach7
0.036903858184814